Research reveals unique features of brain cells linked to neurodevelopmental conditions

7 January 2025, Leuven – Specific brain cells known as layer 5 pyramidal neurons play a vital role in how our brains process information. Research by the team of Prof. Joris de Wit (VIB-KU Leuven) and colleagues highlights the differences between two types of these brain cells —intratelencephalic (IT) neurons and pyramidal tract (PT) neurons—and how these differences may affect their vulnerability to conditions like autism and schizophrenia.

Profiling synapses

Among the neural circuits that let our brain process information, brain cells known as layer 5 pyramidal neurons integrate information from various sources and then distribute it to where it needs to go, like relay hubs in our brain.

To understand how these brain cells exchange information through their synapses (junctions to exchange chemical ‘messages’), the team of Prof. Joris de Wit (VIB-KU Leuven Center for Brain and Disease Research) used a sensitive technique called proteomics to profile the synapses of two types of mouse layer 5 neurons —intratelencephalic (IT) neurons and pyramidal tract (PT) neurons, each with different functions in relaying information.

Working with proteomics expert Prof. Andy Howden (University of Dundee, UK), they discovered that while both types of neurons share some synaptic proteins, they also have unique features that may influence their functions and their susceptibility to certain autistic traits and mental health disorders such as schizophrenia.

Disease vulnerability

"Mapping the synaptic protein composition of layer 5 neurons is an important step in understanding how these neurons are wired into neural circuits and how this process may be affected by neurodevelopmental disorders," says Prof. Joris de Wit. "Our findings suggest that the synapses of layer 5 IT neurons are more susceptible to autism." In follow up studies, supported by the Simons Foundation, the team of Prof. Joris de Wit will investigate whether autism risk genes affect wiring and information processing of layer 5 IT neurons.

Dr. Gabriele Marcassa, first author of the study, adds, “By extending our approach to mapping synaptic profiles of different neuron types in the brain, we can begin to understand their roles in health and disease.”

Publication

Synaptic Signatures and Disease Vulnerabilities of Layer 5 Pyramidal Neurons. Marcassa et al. Nature Communications, 2025. DOI: 10.1038/s41467-024-55470-w.

Funding

This research was supported by FWO – Research Foundation Flanders.


India Jane Wise

India Jane Wise

Science Communications Expert, VIB

About the VIB-KU Leuven Center for Brain & Disease Research

Scientists at the VIB-KU Leuven Center for Brain & Disease study how brain cells are organized and how they communicate with each other. These mechanisms reveal and provide insights into what goes wrong in brain diseases such as Alzheimer's, Parkinson's, ALS, and dystonia. This basic work should ultimately lead to new drugs for use against these currently incurable diseases.

 

 

Share

Latest stories

Website preview
Blocking lipid production in healthy lung cells can reduce lung metastasis
Leuven, 17 March 2026 - Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs. In two complementary studies published in Nature Cell Biology and Cancer Discovery, they show that tumors use lipids produced by lung cells as signals, and that decreasing the lipid production of lung cells can decrease metastasis. The findings point to new therapeutic strategies that target lung cell lipid production, rather than cancer cells themselves, which may also help refine patient selection for ongoing clinical trials targeting this pathway.
press.vib.be
Website preview
Researchers identify major genetic risk factor for rare form of dementia
Antwerp, 12 March 2026 - Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
press.vib.be
Website preview
Protealis Announces Regulatory Approval of its First Biological Solution MagNfixTM and Launch of Five New Soybean Varieties
Ghent (Belgium), 11 March 2026 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI1 (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution, which is a proprietary soybean inoculant seed coating that is designed to support higher soybean yield and protein content. In addition, Protealis has secured the registration of five new soybean varieties across four European countries. This includes the introduction of two new maturity group (MG) 000 soybean varieties in Poland, the registration of its first maturity group 0000 ultra-early soybean variety in France, and a new soy variety registration for Belgium. In Germany, Protealis received registration for its second 00 MG soybean variety suited for the regions in southern Germany...
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be